Comparative Guide
Tax
United States
Devon Bodoh, Joseph Pari, Greg Featherman & Alfonso Dulcey
Weil, Gotshal & Manges LLP supports biotech, pharma, and medical device clients in protecting their assets, with strong work in IP advice and litigation. The firm is also active in corporate matters such as cross-border M&A, strategic alliances, and licensing and collaboration agreements. Additionally, the team handles a broad range of litigation cases, including product liability, securities, commercial disputes, and antitrust. The practice is headed by New York-based Charan Sandhu who focuses on IP and complex commercial and technical matters, including tech transactions. Jeffrey Osterman departed the team to Paul, Weiss, Rifkind, Wharton & Garrison LLP in March 2025.
Legal 500 Editorial commentary
Key clients
- CareDx
- Invitae
- Synthego
- Bio-Rad Laboratories
- Sanofi
- Bruker
- Parse Biosciences
- Pacific Biosciences
- Bluestar Genomics
- Elanco Animal Health
- Personalis
- Eli Lilly
Work highlights
Represented Synthego in a Federal Circuit appeal of a PTAB decision, successfully securing the invalidation of two competitor patents, including all 63 claims in those patents.
Secured decisive wins for Elanco Animal Health in securities fraud class actions in Indiana state and federal courts concerning an alleged COVID-era “channel-stuffing” scheme, and secured a favorable settlement in a related SEC inquiry.
Representing Bio-Rad Laboratories in connection with two patent lawsuits brought by ChromaCode in the Northern District of California, both relating to digital PCR multiplexing.
Practice head
Charan Sandhu